PTEN controls alternative splicing of autism spectrum disorder-associated transcripts in primary neurons
Brain · 07.01.2025 · 148 (1) · 47-54
DOI: 10.1093/brain/awae306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 26.09.2024. Verfasst von Sebastian Rademacher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Molecular Biology a…. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Autism Spectrum Disorder, Alternative Splicing, Neurons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Einstein Stiftung Berlin.
Abstract (Originalsprache)
Phosphatase and tensin homologue (PTEN) is the main antagonist of the phosphatidylinositol-3-kinase (PI3K)/AKT/mTOR signalling pathway and mutated in 10%–20% of individuals with autism spectrum disorder (ASD) exhibiting macrocephaly. Hyperactive mTOR signalling is responsible for some aspects during PTEN-ASD progression, e.g. neuronal hypertrophy and -excitability, but PI3K/mTOR-independent processes have additionally been described. There is emerging evidence that PTEN regulates gene transcription, spliceosome formation and pre-mRNA splicing independently of PI3K/mTOR. Altered splicing is a hallmark of brains from individuals with idiopathic and PTEN-ASD, however, molecular mechanisms are yet to be identified. We performed RNA-sequencing (RNA-Seq), followed by analysis of altered transcript splicing in Pten-deficient primary cortical mouse neurons, which we compared with published data from PTEN-deficient human neuronal stem cells. This analysis identified that transcripts were globally mis-spliced in a developmentally regulated fashion and cluster in synaptic and gene expression regulatory processes. Strikingly, splicing defects following Pten-deficiency represent a significant number of other known ASD-susceptibility genes. Furthermore, we show that exons with strong 3′ splice sites are more frequently mis-spliced under Pten-deficient conditions. Our study indicates that PTEN-ASD is a multifactorial condition involving the dysregulation of other known ASD-susceptibility genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Molecular Biology and Biochemistry, Berlin 10117, Germany.
- Freie Universität Berlin, Institute of Chemistry and Biochemistry, Berlin 14195, Germany.
ORCID-Profile: Marco Preußner, Florian Heyd, Britta J Eickholt
Förderung
- Deutsche Forschungsgemeinschaft
- Einstein Stiftung Berlin
Zitieren
APA
Rademacher, S., Preußner, M., Rehm, M. C., Fuchs, J., Heyd, F., & Eickholt, B. J. (2025). PTEN controls alternative splicing of autism spectrum disorder-associated transcripts in primary neurons. Brain, 148(1), 47-54. https://doi.org/10.1093/brain/awae306
Vancouver
Rademacher S, Preußner M, Rehm MC, Fuchs J, Heyd F, Eickholt BJ. PTEN controls alternative splicing of autism spectrum disorder-associated transcripts in primary neurons. Brain. 2025;148(1):47-54. doi:10.1093/brain/awae306
BibTeX
@article{Rademacher2025,
author = {Rademacher, Sebastian and Preußner, Marco and Rehm, Marie C and Fuchs, Joachim and Heyd, Florian and Eickholt, Britta J},
title = {PTEN controls alternative splicing of autism spectrum disorder-associated transcripts in primary neurons},
journal = {Brain},
year = {2025},
volume = {148},
number = {1},
pages = {47--54},
doi = {10.1093/brain/awae306}
}
EUVIMED